Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cayman
RIG-I Monoclonal Antibody (Clone 1E3)
616
CHF
CHF 616.00
In stock
CAY-25300-100100 µgCHF 616.00
Product Details | |
---|---|
Synonyms | DEAD Box Protein 58; Probable ATP-dependent RNA Helicase DDX58; Retinoic Acid-inducible Gene 1 Protein; RIG-I-like Receptor 1 |
Product Type | Monoclonal Antibody |
Properties | |
Isotype | IgG2b |
Immunogen/Antigen | Recombinant human RIG-I protein AA 232-794. |
Application | ELISA, IHC, WB |
Crossreactivity |
Human Mouse |
Specificity | Recognizes human and mouse RIG-I. |
Formulation | 100 µg of protein G-purified antibody |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Cayman Chemicals. |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | -20°C |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Retinoic acid-inducible gene I (RIG-I), also known as DDX58, is a cytosolic DExD/H-box RNA helicase and an immune sensing receptor encoded by DDX58 in humans. It is composed of a C-terminal repressor domain, a central RNA helicase domain, and two N-terminal caspase recruitment domains (CARDs). Following recognition of viral dsRNA by the C-terminal and helicase domains, the helicase domain induces an ATP-dependent conformational change, allowing for interaction of the CARD domains with mitochondrial antiviral-signaling protein (MAVS) and induction of a type I interferon (IFN) response. RIG-I levels are elevated in the epidermis of patients with psoriasis. DDX58 expression is decreased in tumor tissues from patients with hepatocellular carcinoma (HCC) compared to nontumor hepatic tissue, and low DDX58 expression is associated with poor disease prognosis.